Skip to main content

Luz María Cruz Carlos

Institutions of which they are part

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Luz María Cruz Carlos

Institutions of which they are part

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Research lines

Optimización de procesos preanalíticos y organización de flujos

IP: Luz María Cruz Carlos

Projects

ProLINK-C BCN: Búsqueda prospectiva y vinculación de pacientes con hepatitis C crónica activa en Barcelona

IP: Ariadna Rando Segura
Collaborators: Albert Blanco Grau, Luz María Cruz Carlos, Adrián Najarro Centeno , David Tabernero Caellas
Funding agency: Gilead Sciences, S.L.U.
Funding: 27500
Reference: GILD25_29524
Duration: 01/01/2026 - 30/06/2027

Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT)

IP: -
Collaborators: José Antonio Arranz Amo, Raquel Barquin Del Pino, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Clara Ramírez Serra, Yolanda Villena Ortiz, Joan López Hellin, Albert Blanco Grau, Roser Ferrer Costa, Joaquin Seras Franzoso, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Laura Castillo Ribelles, Clara Carnicer Cáceres, Marina Giralt Arnaiz, Ana Gomez Garcia, Simon Schwartz Navarro, Pablo Gabriel Medina, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Laura Castellote Bellés, Daniel Bravo Nieto, Luz María Cruz Carlos, Clara Sanz Gea, Alba Estela García Fernández, Maria del Pilar Reimundo Diaz-Fierros, Belen Garcia Prats, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), JAUME VIMA BOFARULL, Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT), Diana Fernandes de Rafael, Maria Francesca Cortese , Sandra Mancilla Zamora
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 01173
Duration: 01/01/2022 - 30/06/2025

Medicina mitocondrial: configuración de una estrategia para la identificación genético-molecular de pacientes Oxphos; parte 2 VHIR

IP: Elena García Arumí
Collaborators: Luz María Cruz Carlos
Funding agency: Instituto de Salud Carlos III
Funding: 260513
Reference: PI12/02149
Duration: 01/01/2013 - 31/03/2016

Related news

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The new system, made of cellulose and chitosan, enables sustained release of docetaxel and has demonstrated antitumor activity in preclinical models of ovarian cancer and glioblastoma.

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

Related professionals

Alberto Roque Pérez

Alberto Roque Pérez

Predoctoral researcher
Molecular Imaging and Therapy
Read more
Esperanza Esteban Serna

Esperanza Esteban Serna

Main researcher
Infectious Diseases
Read more
Cristina Bernadó Morales

Cristina Bernadó Morales

Predoctoral researcher
Donation and transplantation of organs, tissues and cells
Read more
Elisabeth Papiol Gallofré

Elisabeth Papiol Gallofré

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.